Nephrectomy

• 

  Subject Areas on Research

  • A decade of minimally invasive donation: experience with more than 1200 laparoscopic donor nephrectomies at a single institution. 
  • A technical modification eliminates early ureteral complications after laparoscopic donor nephrectomy. 
  • A technique for management of multiple renal arteries after laparoscopic donor nephrectomy. 
  • ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer. 
  • ACR appropriateness criteria post-treatment follow-up of renal cell carcinoma. 
  • Active Surveillance Versus Nephron-Sparing Surgery for a Bosniak IIF or III Renal Cyst: A Cost-Effectiveness Analysis. 
  • Adenoid cystic carcinoma of the breast metastatic to the kidney. A clinically symptomatic lesion requiring surgical management. 
  • Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. 
  • Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy. 
  • Adult segmental cystic disease of the kidney: a renal-sparing management approach. 
  • An alternative extraction site for laparoscopic donor nephrectomy. 
  • An unusual presentation: renal tuberculosis. 
  • Analysis of injury in complex organ preservation. 
  • Apparent recurrence of progressive systemic sclerosis in a renal allograft. 
  • Bilateral native nephrectomy improves renal isograft function in rats. 
  • Bilateral nephrectomy by the posterior approach. 
  • Bilateral renal carcinoma in von Hippel-Lindau Disease. 
  • Biochemical and immunological properties of dog brain isorenin. 
  • C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration. 
  • C-C Motif Chemokine Receptor 7 Exacerbates Hypertension Through Effects on T Lymphocyte Trafficking. 
  • C-index is associated with functional outcomes after laparoscopic partial nephrectomy. 
  • CT volumetry is superior to nuclear renography for prediction of residual kidney function in living donors. 
  • Can I Get a Multidisciplinary Consult, Please? Systemic Immunotherapy and the Timing of Cytoreductive Nephrectomy. 
  • Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. 
  • Cecal volvulus following laparoscopic nephrectomy and renal transplantation. 
  • Celiac axis and superior mesenteric artery injury associated with left radical nephrectomy for locally advanced renal cell carcinoma. 
  • Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. 
  • Chemical evidence for early but unsustained growth in the obstructed mouse kidney. 
  • Chylous ascites. 
  • Clinical predictors of renal mass pathological features. 
  • Clinical, pathologic, and functional outcomes after nephron-sparing surgery in patients with a solitary kidney: a multicenter experience. 
  • Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans. 
  • Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours < or =3.5 cm: a single institutional experience. 
  • Complications of enterocystoplasty. 
  • Complications of laparoscopic surgery for urological cancer: a single institution analysis. 
  • Contemporary use of nephron-sparing surgery for children with malignant renal tumors at freestanding children's hospitals. 
  • Controlled survival study of the effects of Tisseel or a combination of FloSeal and Tisseel on major vascular injury and major collecting-system injury during partial nephrectomy in a porcine model. 
  • Correlation of preoperative imaging characteristics with donor outcomes and operative difficulty in laparoscopic donor nephrectomy. 
  • Cyclosporin-A increases synthesis of 1,25-dihydroxyvitamin D3 in the rat and mouse. 
  • Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival. 
  • Debulking nephrectomy in metastatic renal cancer. 
  • Donation after cardiac death: the university of wisconsin experience with renal transplantation. 
  • Donor kidney volume measured by computed tomography is a strong predictor of recipient eGFR in living donor kidney transplantation. 
  • Early Discharge After Radical Nephrectomy: An Analysis of Complications and Readmissions. 
  • Editorial comment. 
  • Editorial comment. 
  • Emphysematous pyelonephritis. 
  • Episode-based Payment Variation for Urologic Cancer Surgery. 
  • Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study. 
  • Evaluation of recurrent glomerulonephritis in kidney allografts. 
  • Ex-vivo ureteroscopy at the time of live donor nephrectomy. 
  • Expanding indications for conservative renal surgery in renal cell carcinoma. 
  • Expression of clusterin in human renal diseases. 
  • Extraperitoneal gas following nephrectomy: patterns and duration. 
  • Factors impacting survival in children with renal cell carcinoma. 
  • Fatal and nonfatal hemorrhagic complications of living kidney donation. 
  • Feasibility of renal transplantation in systemic lupus erythematosus. 
  • Focal therapy for prostate and renal cancer--are we ready for it? 
  • Functional Implications of Renal Tumor Enucleation Relative to Standard Partial Nephrectomy. 
  • Genetic Abrogation of Adenosine A3 Receptor Prevents Uninephrectomy and High Salt-Induced Hypertension. 
  • Hand assisted laparoscopic training for postgraduate urologists: the role of mentoring. 
  • Hand-assisted laparoscopic heminephrectomy in horseshoe kidney. 
  • Hand-assisted laparoscopic nephrectomy for inflammatory renal conditions. 
  • Hand-assisted laparoscopic nephrectomy: the transfer of experience to a new academic center. 
  • Hand-assisted laparoscopic partial nephrectomy without hilar vascular clamping using a saline-cooled, high-density monopolar radiofrequency device. 
  • High dose chemotherapy with autologous peripheral blood progenitor cell transplantation in an anephric child with multiply recurrent Wilms tumor. 
  • How long is too long? The effect of the duration of anaesthesia on the incidence of non-urological complications after surgery. 
  • Hypercalciuria due to combined growth hormone and calcitriol therapy in uremia: effects of growth hormone on mineral homeostasis in 75% nephrectomized weanling rats. 
  • Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus. 
  • Improving outcomes with novel therapies for patients with newly diagnosed renal cell carcinoma. 
  • In-hospital mortality of surgical patients: is there an empiric basis for standard setting? 
  • Incidental discovery of an appendiceal carcinoid tumor and a renal cell carcinoma. 
  • Incidental living donor nephrectomy: a unique expansion of the donor pool. 
  • Intraoperative Monitoring of Pulmonary Artery Physiology With Transesophageal Echocardiography in a Patient With an Extensive Pulmonary Aneurysm Undergoing Partial Nephrectomy. 
  • Intraoperative sonography for the evaluation and management of renal tumors: experience with 100 patients. 
  • Intraoperative transesophageal echocardiography diagnosis of residual tumor fragment after surgical removal of renal cell carcinoma. 
  • Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study. 
  • Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes. 
  • Is living donor nephrectomy a "23-hr stay" procedure? 
  • Ischemic nephropathy and concomitant aortic disease: a ten-year experience. 
  • Kidney cancer. Clinical practice guidelines in oncology. 
  • Kidney cancer. Clinical practice guidelines. 
  • Laparoendoscopic single-site surgery (LESS) for major urological procedures in the pediatric population: A systematic review. 
  • Laparoscopic donor nephrectomy increases the supply of living donor kidneys: a center-specific microeconomic analysis. 
  • Laparoscopic donor nephrectomy with a 23-hour stay: a new standard for transplantation surgery. 
  • Laparoscopic donor nephrectomy: pro. 
  • Laparoscopic nephron-sparing surgery in a Jehovah's Witness patient. 
  • Laparoscopic versus open donor nephrectomy: comparing ureteral complications in the recipients and improving the laparoscopic technique. 
  • Late intrascrotal metastases from renal cell carcinoma. 
  • Long-term effect of uninephrectomy on serum creatinine concentration and arterial blood pressure. 
  • Long-term outcomes of immediate versus delayed nephroureterectomy for upper tract urothelial carcinoma. 
  • Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. 
  • MR angiography and preoperative evaluation for laparoscopic donor nephrectomy. 
  • MYH9 E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration. 
  • Management of small renal tumors with radiofrequency ablation. 
  • Management of small renal tumors: an overview. 
  • May-Thurner syndrome complicating left-sided donor nephrectomy. 
  • Methoxyflurane-induced renal dysfunction. 
  • Minimal mortality of renal surgery. 
  • Minimally invasive surgery for pediatric renal tumors: A systematic review by the APSA Cancer Committee. 
  • Multicystic renal dysplasia. Pathologic and clinical observations in 22 cases. 
  • Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma. 
  • National trends and disparities of minimally invasive surgery for localized renal cancer, 2010 to 2015. 
  • Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial. 
  • Next-day discharge after minimally invasive partial nephrectomy: an analysis of the US National Surgical Quality Improvement Program. 
  • Non-invasive monitoring of tissue oxygenation during laparoscopic donor nephrectomy. 
  • Novel delivery of oligonucleotides using a topical hydrogel tissue sealant in a murine partial nephrectomy model. 
  • Obesity and 30-Day Outcomes Following Minimally Invasive Nephrectomy. 
  • Open surgical partial nephrectomy for upper tract urothelial carcinoma. 
  • Open versus laparoscopic nephroureterectomy: is there really a debate? 
  • Open versus minimally-invasive surgical techniques in pediatric renal tumors: A population-level analysis of in-hospital outcomes. 
  • Outcomes of laparoscopic donor nephrectomy in obese patients. 
  • PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN. 
  • PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer. 
  • Partial and radical nephrectomy in children, adolescents, and young adults: Equivalent readmissions and postoperative complications. 
  • Partial nephrectomy: technique, complications and pathological findings. 
  • Pazopanib in the Treatment of Bilateral Multifocal Renal Oncocytomas: A Case Report. 
  • Plasma renin activity following operations for renovascular hypertension. 
  • PlasmaKinetic bipolar vessel sealing: burst pressures and thermal spread in an animal model. 
  • Post-transplant hypertension in the rat: effects of captopril and native nephrectomy. 
  • Predicting occult multifocality of renal cell carcinoma. 
  • Predictive Factors of Renal Adaptation After Nephrectomy in Kidney Donors. 
  • Predictors of low estimated glomerular filtration rate after living kidney donation in a Southeast Asian population from Singapore. 
  • Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells. 
  • Procurement, preservation, and transport of cadaver kidneys. 
  • Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. 
  • Progressive increase of lithotripter output produces better in-vivo stone comminution. 
  • Prolonged survival with a remnant kidney. 
  • Racial Disparities in Partial Nephrectomy Persist Across Hospital Types: Results From a Population-based Cohort. 
  • Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma. 
  • Reconsidering Physical Activity Restrictions for Mononephric Survivors of Childhood Cancer: A Report From the Children's Oncology Group. 
  • Referral and adjuvant treatment patterns after nephrectomy in high-risk locoregional renal cell carcinoma. 
  • Regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity in the mouse after uninephrectomy. 
  • Renal Thermal Ablation Trends of American Urologists. 
  • Renal cell carcinoma suspected at time of organ donation 2008-2016: A report of the OPTN ad hoc Disease Transmission Advisory Committee Registry. 
  • Renal cell carcinoma. 
  • Renal mass anatomic characteristics and perioperative outcomes of laparoscopic partial nephrectomy: a critical analysis. 
  • Renal response following perioperative ketorolac analgesia in living kidney donation. 
  • Renal tubular cell expression of MHC class II (I-Eb) is insufficient to initiate immune injury in a transgenic kidney transplant model. 
  • Renovascular disease in children and adolescents. 
  • Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant. 
  • Retroperitoneal laparoscopic nephrectomy and other procedures in the upper retroperitoneum using a balloon dissection technique. 
  • Retroperitoneal lymphadenectomy. 
  • Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis. 
  • Risk factors for renal allograft loss in patients with systemic lupus erythematosus. 
  • Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. 
  • Schwannoma of the kidney. 
  • Seven years after laparoscopic radical nephrectomy: oncologic and renal functional outcomes. 
  • Simultaneous kidney transplantation and bilateral native nephrectomy for polycystic kidney disease. 
  • Single-Port robot assisted partial nephrectomy: initial experience and technique with the da Vinci Single-Port platform (IDEAL Phase 1). 
  • Single-site laparoscopic living donor nephrectomy offers comparable perioperative outcomes to conventional laparoscopic living donor nephrectomy at a higher cost. 
  • Stratification of risk factors in renal cell carcinoma. 
  • Surgical management and prognosis of renal cell carcinoma invading the vena cava. 
  • Surgical management of bilateral synchronous kidney tumors: functional and oncological outcomes. 
  • Surgical techniques in right laparoscopic donor nephrectomy. 
  • Survival of patients undergoing cytoreductive surgery for metastatic renal cell carcinoma in the targeted-therapy era. 
  • Synchronous resection of esophageal cancer and other organ malignancies: A systematic review. 
  • Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. 
  • Tailoring the 'Perfect Fit' for Renal Transplant Recipients with End-stage Polycystic Kidney Disease: Indications and Timing of Native Nephrectomy. 
  • The Effect of Psychiatric History on Pain and Related Outcomes Among Living Kidney Donors. 
  • The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program. 
  • The feedback regulation of angiotensinogen production by components of the renin-angiotensin system. 
  • The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER? 
  • The general public's concerns about clinical risk in live kidney donation. 
  • The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. 
  • The landscape of contemporary clinical trials for untreated metastatic clear cell renal cell carcinoma. 
  • The rise of ablative technologies for treating the small renal mass. 
  • The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. 
  • Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma. 
  • Transmission of cancer with cadaveric donor organs. 
  • Transperitoneal laparoscopic nephrectomy: training, technique, and results. 
  • Transplant approach establishes that kidneys are responsible for serum CSF-1 but require a stimulus in MRL-lpr mice. 
  • Transplantation for polycystic kidney disease. 
  • Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. 
  • Treatment of localised renal cell carcinoma. 
  • Treatment strategies in renal carcinoma. 
  • Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small renal cell carcinoma. 
  • Urinary aquaporin 1 and perilipin 2: Can these novel markers accurately characterize small renal masses and help guide patient management? 
  • Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer. 
  • Urologic surgery. 
  • Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis. 
  • VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? 
  • What's new in transplantation. 
  • Why do secondary cadaver renal transplants succeed? Results of the South-Eastern Organ Procurement Foundation prospective study, 1977-1982. 
  • Wilms Tumor After Orthotopic Liver Transplant in a Patient With Alagille Syndrome. 
  • Words of wisdom. Re: final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance. 
• 

  Keywords of People

  • Inman, Brant Allen, Professor of Surgery, Surgery, Urology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology